메뉴 건너뛰기




Volumn 19, Issue 4, 2010, Pages 428-431

Antiphospholipid syndrome: Critical analysis of the diagnostic path

Author keywords

Antibodies; Phospholipid; Pregnancy; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

EID: 77951247060     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309360543     Document Type: Review
Times cited : (32)

References (26)
  • 1
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S., Lockshin MD, Atsumi M., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, M.3
  • 3
    • 34247336928 scopus 로고    scopus 로고
    • 2-Glycoprotein I activity
    • DOI 10.1016/j.thromres.2006.07.014, PII S0049384806002854
    • Pengo V., Biasiolo A., Bison E., Chantarangkul V., Tripodi A. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Thromb Res 2007 ; 120: 127-133. (Pubitemid 46628706)
    • (2007) Thrombosis Research , vol.120 , Issue.1 , pp. 127-133
    • Pengo, V.1    Biasiolo, A.2    Bison, E.3    Chantarangkul, V.4    Tripodi, A.5
  • 4
    • 13544276197 scopus 로고    scopus 로고
    • 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
    • DOI 10.1182/blood-2004-09-3387
    • de Laat B., Derksen RH, Urbanus RT, de Groot PG IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LA, and their presence correlates strongly with thrombosis. Blood 2005 ; 105: 1540-1545. (Pubitemid 40223671)
    • (2005) Blood , vol.105 , Issue.4 , pp. 1540-1545
    • De Laat, B.1    Derksen, R.H.W.M.2    Urbanus, R.T.3    De Groot, P.G.4
  • 5
    • 0034852546 scopus 로고    scopus 로고
    • The risk of overdiagnosis of antiphospholipid antibody syndrome
    • Pengo V., Biasiolo A. The risk of overdiagnosis of antiphospholipid antibody syndrome. Thromb Haemost 2001 ; 86: 933. (Pubitemid 32834210)
    • (2001) Thrombosis and Haemostasis , vol.86 , Issue.3 , pp. 933
    • Pengo, V.1    Biasiolo, A.2
  • 6
    • 0037370733 scopus 로고    scopus 로고
    • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
    • DOI 10.1182/blood-2002-02-0441
    • Galli M., Luciani D., Bertolini G., Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003 ; 101: 1827-1832. (Pubitemid 36237580)
    • (2003) Blood , vol.101 , Issue.5 , pp. 1827-1832
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 7
    • 0141958839 scopus 로고    scopus 로고
    • Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
    • DOI 10.1182/blood-2002-11-3334
    • Galli M., Luciani B., Bertolini G., Barbui T. Anti-β2-Glycoprotein I, anti-prothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003 ; 102: 2717-2723. (Pubitemid 37248837)
    • (2003) Blood , vol.102 , Issue.8 , pp. 2717-2723
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 11
    • 0031055748 scopus 로고    scopus 로고
    • 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids
    • Pengo V., Balestrieri G., Tincani A., Spatola L., Biasiolo A., Brocco T. Utilization of dilute Russells viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. Thromb Haemost 1997 ; 77: 123-126. (Pubitemid 27064980)
    • (1997) Thrombosis and Haemostasis , vol.77 , Issue.1 , pp. 123-126
    • Pengo, V.1    Balestrieri, G.2    Tincani, A.3    Spatola, L.4    Biasiolo, A.5    Brocco, T.6
  • 12
    • 70449390005 scopus 로고    scopus 로고
    • The association between circulating antibodies against domain i of beta2-glycoprotein i and thrombosis: An international multicenter study
    • de Laat B., Pengo V., Pabinger I., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009 ; DOI 10.1111/j.1538-7836.2009.03588.
    • (2009) J Thromb Haemost
    • De Laat, B.1    Pengo, V.2    Pabinger, I.3
  • 13
    • 52449102771 scopus 로고    scopus 로고
    • Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification
    • Ruffatti A., Olivieri S., Tonello M., et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost 2008 ; 6: 1693-1696.
    • (2008) J Thromb Haemost , vol.6 , pp. 1693-1696
    • Ruffatti, A.1    Olivieri, S.2    Tonello, M.3
  • 14
    • 0033564338 scopus 로고    scopus 로고
    • Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein
    • Arvieux J., Pernod G., Regnault V., Darnige L., Garin J. Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein. Blood 1999 ; 93: 4248-4255. (Pubitemid 29279267)
    • (1999) Blood , vol.93 , Issue.12 , pp. 4248-4255
    • Arvieux, J.1    Pernod, G.2    Regnault, V.3    Darnige, L.4    Garin, J.5
  • 16
    • 0034852546 scopus 로고    scopus 로고
    • The risk of overdiagnosis of antiphospholipid antibody syndrome
    • Pengo V., Biasiolo A. The risk of overdiagnosis of antiphospholipid antibody syndrome. Thromb Haemost 2001 ; 86: 933. (Pubitemid 32834210)
    • (2001) Thrombosis and Haemostasis , vol.86 , Issue.3 , pp. 933
    • Pengo, V.1    Biasiolo, A.2
  • 17
    • 2542554965 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: Multiple mechanisms
    • Mackworth-Young CG Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004 ; 136: 393-401.
    • (2004) Clin Exp Immunol , vol.136 , pp. 393-401
    • MacKworth-Young, C.G.1
  • 18
    • 34948886689 scopus 로고    scopus 로고
    • Pregnancies complicated with antiphospholipid syndrome: The pathogenic mechanism of antiphospholipid antibodies. A review of the literature
    • DOI 10.1196/annals.1422.054, Autoimmunity, Part D: Autoimmune Disease, Annus Mirabilis
    • Di Simone N., Meroni PL, DAsta M., et al. Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies A review of the literature. Ann NY Acad Sci 2007 ; 1108: 505-514. (Pubitemid 47528765)
    • (2007) Annals of the New York Academy of Sciences , vol.1108 , pp. 505-514
    • Di Simone, N.1    Luigi, M.P.2    Marco, D.3    Fiorella, D.N.4    Silvia, D.5    Clara, D.M.6    Alessandro, C.7
  • 20
    • 33846930928 scopus 로고    scopus 로고
    • Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies
    • Shamonki JM, Salmon JE, Hyjek E., Baergen RN Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 2007 ; 196: 167.
    • (2007) Am J Obstet Gynecol , vol.196 , pp. 167
    • Shamonki, J.M.1    Salmon, J.E.2    Hyjek, E.3    Baergen, R.N.4
  • 21
    • 16644373424 scopus 로고    scopus 로고
    • What is antiphospholipid syndrome?
    • Erkan D., Lockshin MD What is antiphospholipid syndrome? Curr Rheumatol Rep 2004 ; 6: 451-457.
    • (2004) Curr Rheumatol Rep , vol.6 , pp. 451-457
    • Erkan, D.1    Lockshin, M.D.2
  • 23
    • 0037273987 scopus 로고    scopus 로고
    • The place of beta 2 glycoprotein 1 in the assessment of antiphospholipid syndrome
    • DOI 10.1097/00001721-200301000-00001
    • Myers B., Gould J. The place ofβ2-glycoprotein I in the assessment of antiphospholipid syndrome. Blood Coag Fibrinolysis 2003 ; 14: 1-2. (Pubitemid 36206714)
    • (2003) Blood Coagulation and Fibrinolysis , vol.14 , Issue.1 , pp. 1-2
    • Myers, B.1    Gould, J.2
  • 25
    • 77951235778 scopus 로고    scopus 로고
    • Clinical course of high risk patients diagnosed with Antiphospholipid Syndrome (APS)
    • Pengo V., Ruffatti A., Legnani C., et al. Clinical course of high risk patients diagnosed with Antiphospholipid Syndrome (APS). J Thromb Haemost 2009 Oct 30; [Epub ahead of print] PMID: 19874470 [PubMed - as supplied by publisher].
    • (2009) J Thromb Haemost
    • Pengo, V.1    Ruffatti, A.2    Legnani, C.3
  • 26
    • 70350004861 scopus 로고    scopus 로고
    • Update of the guidelines for lupus anticoagulant detection
    • Pengo V., Tripodi A., Reber G., et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009 ; 10: 1737-1740.
    • (2009) J Thromb Haemost , vol.10 , pp. 1737-1740
    • Pengo, V.1    Tripodi, A.2    Reber, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.